Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

FIM Study of the LAmbre™ II LAA Occluder in Non-Valvular AF Patients

NCT: NCT07385599 · RECRUITING

NCT IDNCT07385599
StatusRECRUITING
Start Date2026-01-19
Completion2028-03-01
SponsorLifetech Scientific (Shenzhen) Co., Ltd. (INDUSTRY)
First posted
Last updated

Brief Summary

To evaluate the preliminary safety and feasibility of the LAmbreTM II Left Atrial Appendage Occluder and the Occluder Delivery System in patients with non-valvular atrial fibrillation who are at increased risk for stroke and systemic embolism.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑